BRIGHAM AND WOMEN'S HOSPITAL
Core B - Microbial glycan microarray core
Core B - Microbial glycan microarray core is a funding opportunity from BRIGHAM AND WOMEN'S HOSPITAL, up to 419110, closing July 31, 2029.
Jul 31, 2029
(1096d left)Overview
SUMMARY: Naturally occurring anti-ABO(H) antibodies represent the most common barrier to transfusion and transplantation. These antibodies can vary wildly in titer and specificity, resulting in distinct clinical outcomes following ABO(H) incompatibility. Formation of these antibodies is linked directly to host…